Holen Sie sich die Stockscreener-App
5.55
2.80%
-0.16
Handel nachbörslich:
5.55
Schlusskurs vom Vortag:
$5.71
Offen:
$5.77
24-Stunden-Volumen:
118.31K
Relative Volume:
0.41
Marktkapitalisierung:
$102.24M
Einnahmen:
$62.81M
Nettoeinkommen (Verlust:
$-13.75M
KGV:
-6.9375
EPS:
-0.8
Netto-Cashflow:
$153.00K
1W Leistung:
+2.21%
1M Leistung:
+14.20%
6M Leistung:
-49.13%
1J Leistung:
-60.69%
1-Tages-Spanne:
$5.50
$5.77
1-Wochen-Bereich:
$5.15
$5.86
52-Wochen-Spanne:
$3.78
$16.64
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Vergleichen Sie OPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
5.55 | 102.24M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
233.26 | 37.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.06 | 12.79B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
59.10 | 11.03B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
110.42 | 9.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
57.39 | 9.04B | 640.44M | -743.28M | -206.93M | -11.29 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-11-01 | Eingeleitet | Stifel | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
OptimizeRx Co. (NASDAQ:OPRX) Receives $9.06 Consensus Target Price from Brokerages - Defense World
Chuck Royce's Strategic Acquisition of OptimizeRx Corp Shares - GuruFocus.com
OptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx (NASDAQ:OPRX) adds US$12m to market cap in the past 7 days, though investors from three years ago are still down 87% - Simply Wall St
Strong week for OptimizeRx (NASDAQ:OPRX) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance
Contrasting Ucommune International (NASDAQ:UK) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Sold by Jane Street Group LLC - Defense World
OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook - MSN
OptimizeRx's SWOT analysis: digital health stock faces headwinds amid growth potential - Investing.com
RBC Capital Downgrades OptimizeRx (OPRX) - MSN
Royal Bank of Canada Reiterates "Sector Perform" Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
Barclays PLC Purchases 21,060 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Geode Capital Management LLC Sells 20,126 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OMNIQ Corporation Issues Press Release on January 6th, 2025OMNIQ CORP. recently released a notable press release on January 6, 2025. The content of this press release was unveiled as part of the company’s submission of a Form 8-K filing to the Securi - Defense World
Inseego Appoints Juho Sarvikas as Chief Executive Officer and Announces New Board MembersSAN DIEGO – Inseego Corp. (NASDAQ: INSG) has recently announced the appointment of Juho Sarvikas as Chief Executive Officer, effective January 6, 2025. Th - Defense World
White Gold (CVE:WGO) Shares Down 0.9% – What’s Next? - Defense World
Shepherd Ave Capital Acquisition Co. Unit’s Quiet Period Will Expire on January 14th (NASDAQ:SPHAU) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Receives $9.19 Average Target Price from Brokerages - Defense World
Keyence (OTCMKTS:KYCCF) Shares Up 0.5% – Here’s What Happened - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Receives $9.19 Consensus Target Price from Brokerages - MarketBeat
Reviewing OptimizeRx (NASDAQ:OPRX) & Maximus (NYSE:MMS) - Defense World
Glucotrack Receives Notice from Nasdaq Regarding Bid Price Rule Compliance**Washington, D.C., December 31, 2024 – Glucotrack, Inc. (NASDAQ: GCTK) recently received notification from the Nasdaq Stock Market LLC (“Nasdaq”) concerning its bid price f - Defense World
Palomar Holdings, Inc. Extends CEO Mac Armstrong’s Employment AgreementPalomar Holdings, Inc. (NASDAQ: PLMR) announced on December 23, 2024, that the company has entered into an executive employment agreement with Mac Armstrong, the Chi - Defense World
AmpliTech Group Enters Securities Purchase Agreement, Announces OfferingOn December 27, 2024, AmpliTech Group, Inc. (NASDAQ: AMPG) disclosed in a Form 8-K filing with the Securities and Exchange Commission that it has entered into a Securities P - Defense World
FACT II Acquisition Corp. Unit’s (NASDAQ:FACTU) Quiet Period To End on January 6th - Defense World
TRU Precious Metals (CVE:TRU) Shares Down 25% – Should You Sell? - Defense World
OptimizeRx price target lowered to $13 from $17 at B. Riley - Yahoo Finance
Lake Street reiterates Buy on OptimizeRx after ‘surprising’ CEO departure - Yahoo Finance
OptimizeRx’s (OPRX) Buy Rating Reaffirmed at Lake Street Capital - Defense World
OptimizeRx (NASDAQ:OPRX) Given New $13.00 Price Target at B. Riley - Defense World
Stifel maintains Buy rating on OptimizeRX stock citing shift to consistent growth strategy - Investing.com India
Lake Street holds OptimizeRX stock at Buy list despite CEO exit - Investing.com Australia
OptimizeRx's (OPRX) Buy Rating Reaffirmed at Lake Street Capital - MarketBeat
Lake Street holds OptimizeRX stock at Buy list despite CEO exit By Investing.com - Investing.com South Africa
OptimizeRx Corp. Announces Chief Executive Officer Changes - Marketscreener.com
OptimizeRX stock retains Buy rating as company transitions to new leadership team - Investing.com
OptimizeRx CEO to step down, interim successor named By Investing.com - Investing.com Australia
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO - EIN News
OptimizeRx CEO to step down, interim successor named - Investing.com
OptimizeRx (NASDAQ:OPRX) Research Coverage Started at Stephens - Defense World
OptimizeRx CEO Steps Down After 9-Year Growth Era; Company Projects Strong 2024 Outlook - StockTitan
OptimizeRx Co. (NASDAQ:OPRX) Stake Increased by BNP Paribas Financial Markets - Defense World
Stephens & Co. Initiates Coverage of OptimizeRx (OPRX) with Equal-Weight Recommendation - MSN
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts - Benzinga
OptimizeRx (NASDAQ:OPRX) Earns Equal Weight Rating from Analysts at Stephens - MarketBeat
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.48%
1.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):